Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid and reproductive hormones, BMI, and excess hair are linked in Iraqi women with PCOS.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

A 36-year-old woman with low potassium levels was found to have Cushing disease, and after treatment, her potassium levels normalized.

The patient with a misplaced pituitary gland and interrupted pituitary stalk is being treated with hormone replacement.

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Finasteride is effective and safe for treating hidradenitis suppurativa in both adults and some younger patients.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

The guide helps dermatologists diagnose and treat different types of hair loss.

Auriculotherapy and Aslagh capsules are as effective as metformin for treating PCOS symptoms, with auriculotherapy slightly better for reducing hair growth.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Lasers and intense pulsed light can safely and effectively remove hair by targeting hair follicles.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Adolescents with abnormal uterine bleeding often have polycystic ovarian syndrome and insulin resistance.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Bicalutamide may help treat female pattern hair loss.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.